A Top New York Hospital, an Unapproved Treatment and an F.D.A. Warning
A product made from umbilical cord blood was used in spine surgeries at a Manhattan hospital. After a federal warning came an internal complaint: Patients should have been told.
Source: NYT Health - Category: Consumer Health News Authors: Ellen Gabler, Steve Eder and Allie Pitchon Tags: Hospitals Blood Biotechnology and Bioengineering Ethics and Official Misconduct New York-Presbyterian Hospital Food and Drug Administration Surgery and Surgeons Regulation and Deregulation of Industry Medicine and Health Research Burst Source Type: news
More News: Biotechnology | Food and Drug Administration (FDA) | Health | Hospitals | Medical Ethics | Warnings